International Conference on Pharmaceutical Oncology

Important dates

1. 1 Nov

   Abstract / full paper deadline

   Passed

2. 28 Nov

   Conference

   Texas, Texas, USA

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

The key intention of ICPO is to provide opportunity for the global participants to share their ideas and experience in person with their peers expected to join from different parts on the world. In addition this gathering will help the delegates to establish research or business relations as well as to find international linkage for future collaborations in their career path. We hope that ICPO outcome will lead to significant contributions to the knowledge base in these up-to-date scientific fields in scope.

Topics and scope

• Advances in Anticancer Drug Development
• Targeted Therapies and Molecular Mechanisms in Oncology
• Nanomedicine Applications in Cancer Treatment
• Pharmacogenomics and Personalized Cancer Therapy
• Immunotherapy and Monoclonal Antibodies in Cancer
• Drug Delivery Systems for Oncology Applications
• Translational Oncology: From Bench to Bedside
• Clinical Trials and Regulatory Strategies for Oncology Drugs
• Chemo-resistance Mechanisms and Overcoming Drug Resistance
• Role of Natural Products in Anticancer Drug Discovery
• Oncology Pharmacokinetics and Pharmacodynamics
• Cancer Vaccines: Design, Development, and Clinical Application
• Artificial Intelligence in Oncology Drug Discovery
• Biosimilars in Oncology: Challenges and Opportunities
• Combination Therapies: Synergistic Approaches in Cancer Treatment
• Pediatric Oncology Pharmacology
• Radiopharmaceuticals and Theranostics in Cancer Care
• Ethical and Legal Issues in Oncology Drug Trials
• Big Data Analytics and Machine Learning in Oncology Pharmacology
• Emerging Trends in Epigenetic Therapies for Cancer

Call for papers

The call for papers closed on 1 November 2026. For other conferences, see open calls for papers in this field.